 | • レポートコード：MRC23Q36342 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の唾液スクリーニング市場について調査・分析し、世界の唾液スクリーニング市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（PCR、RT-qPCR、ラテラルフローアッセイ）、用途別セグメント分析（診断検査室、病院/クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher scientific、Qiagen、Hologic、Takara Bio Inc、Arcis Biotechnology Limited、GeneProof、Abacus ALS、Chai Inc.、Kolplast Group、Lucence Health INc、Vitagene、Therma Bright Inc、ACON Laboratories, Inc、TODA PHARMA、Norgen Biotek Corp.、Assure Tech. (Hangzhou) Co., Ltd、Beijing Hotgen Biotech Co., Ltd、Nantong Diagnos Biotechnology Co., Ltd、NeuMoDx Molecular, Inc.、KYODO INTERNATIONAL INC.、Canvax、Zymo Research Corporation.、Salimetrics、NEST Scientific USA、Miraclean Technology Co. Ltd、Mawi DNA Technologies、Cell Projects Ltd.などが含まれています。世界の唾液スクリーニング市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、唾液スクリーニング市場規模を推定する際に考慮しました。本レポートは、唾液スクリーニングの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、唾液スクリーニングに関するビジネス上の意思決定に役立てることを目的としています。 ・唾液スクリーニング市場の概要 - 唾液スクリーニングのタイプ別セグメント - 世界の唾液スクリーニング市場規模：タイプ別分析（PCR、RT-qPCR、ラテラルフローアッセイ） - 唾液スクリーニングの用途別セグメント - 世界の唾液スクリーニング市場規模：用途別分析（診断検査室、病院/クリニック、その他） - 世界の唾液スクリーニング市場規模予測（2018年-2029年） ・唾液スクリーニング市場の成長トレンド - 唾液スクリーニングの地域別市場規模（2018年-2029年） - 唾液スクリーニング市場ダイナミクス - 唾液スクリーニングの業界動向 - 唾液スクリーニング市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：PCR、RT-qPCR、ラテラルフローアッセイ - 世界の唾液スクリーニングのタイプ別市場規模（2018年-2023年） - 世界の唾液スクリーニングのタイプ別市場規模（2024年-2029年） ・用途別セグメント：診断検査室、病院/クリニック、その他 - 世界の唾液スクリーニングの用途別市場規模（2018年-2023年） - 世界の唾液スクリーニングの用途別市場規模（2024年-2029年） ・唾液スクリーニングの地域別市場規模 - 北米の唾液スクリーニング市場規模（2018年-2029年） - アメリカの唾液スクリーニング市場規模（2018年-2029年） - ヨーロッパの唾液スクリーニング市場規模（2018年-2029年） - アジア太平洋の唾液スクリーニング市場規模（2018年-2029年） - 中国の唾液スクリーニング市場規模（2018年-2029年） - 日本の唾液スクリーニング市場規模（2018年-2029年） - 韓国の唾液スクリーニング市場規模（2018年-2029年） - インドの唾液スクリーニング市場規模（2018年-2029年） - オーストラリアの唾液スクリーニング市場規模（2018年-2029年） - 中南米の唾液スクリーニング市場規模（2018年-2029年） - 中東・アフリカの唾液スクリーニング市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher scientific、Qiagen、Hologic、Takara Bio Inc、Arcis Biotechnology Limited、GeneProof、Abacus ALS、Chai Inc.、Kolplast Group、Lucence Health INc、Vitagene、Therma Bright Inc、ACON Laboratories, Inc、TODA PHARMA、Norgen Biotek Corp.、Assure Tech. (Hangzhou) Co., Ltd、Beijing Hotgen Biotech Co., Ltd、Nantong Diagnos Biotechnology Co., Ltd、NeuMoDx Molecular, Inc.、KYODO INTERNATIONAL INC.、Canvax、Zymo Research Corporation.、Salimetrics、NEST Scientific USA、Miraclean Technology Co. Ltd、Mawi DNA Technologies、Cell Projects Ltd. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Saliva-based Screening market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Saliva-based Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Saliva-based Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Saliva-based Screening in Diagnostic Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Saliva-based Screening include Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, Chai Inc. and Kolplast Group, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Saliva-based Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Saliva-based Screening.
The Saliva-based Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Saliva-based Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Saliva-based Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher scientific
Qiagen
Hologic
Takara Bio Inc
Arcis Biotechnology Limited
GeneProof
Abacus ALS
Chai Inc.
Kolplast Group
Lucence Health INc
Vitagene
Therma Bright Inc
ACON Laboratories, Inc
TODA PHARMA
Norgen Biotek Corp.
Assure Tech. (Hangzhou) Co., Ltd
Beijing Hotgen Biotech Co., Ltd
Nantong Diagnos Biotechnology Co., Ltd
NeuMoDx Molecular, Inc.
KYODO INTERNATIONAL INC.
Canvax
Zymo Research Corporation.
Salimetrics
NEST Scientific USA
Miraclean Technology Co. Ltd
Mawi DNA Technologies
Cell Projects Ltd.
Segment by Type
Direct Sample to PCR
RT-qPCR
Lateral Flow Assays
Segment by Application
Diagnostic Laboratories
Hospitals & Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Saliva-based Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Saliva-based Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Direct Sample to PCR
1.2.3 RT-qPCR
1.2.4 Lateral Flow Assays
1.3 Market by Application
1.3.1 Global Saliva-based Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals & Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Saliva-based Screening Market Perspective (2018-2029)
2.2 Saliva-based Screening Growth Trends by Region
2.2.1 Global Saliva-based Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Saliva-based Screening Historic Market Size by Region (2018-2023)
2.2.3 Saliva-based Screening Forecasted Market Size by Region (2024-2029)
2.3 Saliva-based Screening Market Dynamics
2.3.1 Saliva-based Screening Industry Trends
2.3.2 Saliva-based Screening Market Drivers
2.3.3 Saliva-based Screening Market Challenges
2.3.4 Saliva-based Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Saliva-based Screening Players by Revenue
3.1.1 Global Top Saliva-based Screening Players by Revenue (2018-2023)
3.1.2 Global Saliva-based Screening Revenue Market Share by Players (2018-2023)
3.2 Global Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Saliva-based Screening Revenue
3.4 Global Saliva-based Screening Market Concentration Ratio
3.4.1 Global Saliva-based Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Saliva-based Screening Revenue in 2022
3.5 Saliva-based Screening Key Players Head office and Area Served
3.6 Key Players Saliva-based Screening Product Solution and Service
3.7 Date of Enter into Saliva-based Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Saliva-based Screening Breakdown Data by Type
4.1 Global Saliva-based Screening Historic Market Size by Type (2018-2023)
4.2 Global Saliva-based Screening Forecasted Market Size by Type (2024-2029)
5 Saliva-based Screening Breakdown Data by Application
5.1 Global Saliva-based Screening Historic Market Size by Application (2018-2023)
5.2 Global Saliva-based Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Saliva-based Screening Market Size (2018-2029)
6.2 North America Saliva-based Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Saliva-based Screening Market Size by Country (2018-2023)
6.4 North America Saliva-based Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Saliva-based Screening Market Size (2018-2029)
7.2 Europe Saliva-based Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Saliva-based Screening Market Size by Country (2018-2023)
7.4 Europe Saliva-based Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Saliva-based Screening Market Size (2018-2029)
8.2 Asia-Pacific Saliva-based Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Saliva-based Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Saliva-based Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Saliva-based Screening Market Size (2018-2029)
9.2 Latin America Saliva-based Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Saliva-based Screening Market Size by Country (2018-2023)
9.4 Latin America Saliva-based Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Saliva-based Screening Market Size (2018-2029)
10.2 Middle East & Africa Saliva-based Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Saliva-based Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Saliva-based Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher scientific
11.1.1 Thermo Fisher scientific Company Detail
11.1.2 Thermo Fisher scientific Business Overview
11.1.3 Thermo Fisher scientific Saliva-based Screening Introduction
11.1.4 Thermo Fisher scientific Revenue in Saliva-based Screening Business (2018-2023)
11.1.5 Thermo Fisher scientific Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Saliva-based Screening Introduction
11.2.4 Qiagen Revenue in Saliva-based Screening Business (2018-2023)
11.2.5 Qiagen Recent Development
11.3 Hologic
11.3.1 Hologic Company Detail
11.3.2 Hologic Business Overview
11.3.3 Hologic Saliva-based Screening Introduction
11.3.4 Hologic Revenue in Saliva-based Screening Business (2018-2023)
11.3.5 Hologic Recent Development
11.4 Takara Bio Inc
11.4.1 Takara Bio Inc Company Detail
11.4.2 Takara Bio Inc Business Overview
11.4.3 Takara Bio Inc Saliva-based Screening Introduction
11.4.4 Takara Bio Inc Revenue in Saliva-based Screening Business (2018-2023)
11.4.5 Takara Bio Inc Recent Development
11.5 Arcis Biotechnology Limited
11.5.1 Arcis Biotechnology Limited Company Detail
11.5.2 Arcis Biotechnology Limited Business Overview
11.5.3 Arcis Biotechnology Limited Saliva-based Screening Introduction
11.5.4 Arcis Biotechnology Limited Revenue in Saliva-based Screening Business (2018-2023)
11.5.5 Arcis Biotechnology Limited Recent Development
11.6 GeneProof
11.6.1 GeneProof Company Detail
11.6.2 GeneProof Business Overview
11.6.3 GeneProof Saliva-based Screening Introduction
11.6.4 GeneProof Revenue in Saliva-based Screening Business (2018-2023)
11.6.5 GeneProof Recent Development
11.7 Abacus ALS
11.7.1 Abacus ALS Company Detail
11.7.2 Abacus ALS Business Overview
11.7.3 Abacus ALS Saliva-based Screening Introduction
11.7.4 Abacus ALS Revenue in Saliva-based Screening Business (2018-2023)
11.7.5 Abacus ALS Recent Development
11.8 Chai Inc.
11.8.1 Chai Inc. Company Detail
11.8.2 Chai Inc. Business Overview
11.8.3 Chai Inc. Saliva-based Screening Introduction
11.8.4 Chai Inc. Revenue in Saliva-based Screening Business (2018-2023)
11.8.5 Chai Inc. Recent Development
11.9 Kolplast Group
11.9.1 Kolplast Group Company Detail
11.9.2 Kolplast Group Business Overview
11.9.3 Kolplast Group Saliva-based Screening Introduction
11.9.4 Kolplast Group Revenue in Saliva-based Screening Business (2018-2023)
11.9.5 Kolplast Group Recent Development
11.10 Lucence Health INc
11.10.1 Lucence Health INc Company Detail
11.10.2 Lucence Health INc Business Overview
11.10.3 Lucence Health INc Saliva-based Screening Introduction
11.10.4 Lucence Health INc Revenue in Saliva-based Screening Business (2018-2023)
11.10.5 Lucence Health INc Recent Development
11.11 Vitagene
11.11.1 Vitagene Company Detail
11.11.2 Vitagene Business Overview
11.11.3 Vitagene Saliva-based Screening Introduction
11.11.4 Vitagene Revenue in Saliva-based Screening Business (2018-2023)
11.11.5 Vitagene Recent Development
11.12 Therma Bright Inc
11.12.1 Therma Bright Inc Company Detail
11.12.2 Therma Bright Inc Business Overview
11.12.3 Therma Bright Inc Saliva-based Screening Introduction
11.12.4 Therma Bright Inc Revenue in Saliva-based Screening Business (2018-2023)
11.12.5 Therma Bright Inc Recent Development
11.13 ACON Laboratories, Inc
11.13.1 ACON Laboratories, Inc Company Detail
11.13.2 ACON Laboratories, Inc Business Overview
11.13.3 ACON Laboratories, Inc Saliva-based Screening Introduction
11.13.4 ACON Laboratories, Inc Revenue in Saliva-based Screening Business (2018-2023)
11.13.5 ACON Laboratories, Inc Recent Development
11.14 TODA PHARMA
11.14.1 TODA PHARMA Company Detail
11.14.2 TODA PHARMA Business Overview
11.14.3 TODA PHARMA Saliva-based Screening Introduction
11.14.4 TODA PHARMA Revenue in Saliva-based Screening Business (2018-2023)
11.14.5 TODA PHARMA Recent Development
11.15 Norgen Biotek Corp.
11.15.1 Norgen Biotek Corp. Company Detail
11.15.2 Norgen Biotek Corp. Business Overview
11.15.3 Norgen Biotek Corp. Saliva-based Screening Introduction
11.15.4 Norgen Biotek Corp. Revenue in Saliva-based Screening Business (2018-2023)
11.15.5 Norgen Biotek Corp. Recent Development
11.16 Assure Tech. (Hangzhou) Co., Ltd
11.16.1 Assure Tech. (Hangzhou) Co., Ltd Company Detail
11.16.2 Assure Tech. (Hangzhou) Co., Ltd Business Overview
11.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Introduction
11.16.4 Assure Tech. (Hangzhou) Co., Ltd Revenue in Saliva-based Screening Business (2018-2023)
11.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Development
11.17 Beijing Hotgen Biotech Co., Ltd
11.17.1 Beijing Hotgen Biotech Co., Ltd Company Detail
11.17.2 Beijing Hotgen Biotech Co., Ltd Business Overview
11.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Introduction
11.17.4 Beijing Hotgen Biotech Co., Ltd Revenue in Saliva-based Screening Business (2018-2023)
11.17.5 Beijing Hotgen Biotech Co., Ltd Recent Development
11.18 Nantong Diagnos Biotechnology Co., Ltd
11.18.1 Nantong Diagnos Biotechnology Co., Ltd Company Detail
11.18.2 Nantong Diagnos Biotechnology Co., Ltd Business Overview
11.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Introduction
11.18.4 Nantong Diagnos Biotechnology Co., Ltd Revenue in Saliva-based Screening Business (2018-2023)
11.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Development
11.19 NeuMoDx Molecular, Inc.
11.19.1 NeuMoDx Molecular, Inc. Company Detail
11.19.2 NeuMoDx Molecular, Inc. Business Overview
11.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Introduction
11.19.4 NeuMoDx Molecular, Inc. Revenue in Saliva-based Screening Business (2018-2023)
11.19.5 NeuMoDx Molecular, Inc. Recent Development
11.20 KYODO INTERNATIONAL INC.
11.20.1 KYODO INTERNATIONAL INC. Company Detail
11.20.2 KYODO INTERNATIONAL INC. Business Overview
11.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Introduction
11.20.4 KYODO INTERNATIONAL INC. Revenue in Saliva-based Screening Business (2018-2023)
11.20.5 KYODO INTERNATIONAL INC. Recent Development
11.21 Canvax
11.21.1 Canvax Company Detail
11.21.2 Canvax Business Overview
11.21.3 Canvax Saliva-based Screening Introduction
11.21.4 Canvax Revenue in Saliva-based Screening Business (2018-2023)
11.21.5 Canvax Recent Development
11.22 Zymo Research Corporation.
11.22.1 Zymo Research Corporation. Company Detail
11.22.2 Zymo Research Corporation. Business Overview
11.22.3 Zymo Research Corporation. Saliva-based Screening Introduction
11.22.4 Zymo Research Corporation. Revenue in Saliva-based Screening Business (2018-2023)
11.22.5 Zymo Research Corporation. Recent Development
11.23 Salimetrics
11.23.1 Salimetrics Company Detail
11.23.2 Salimetrics Business Overview
11.23.3 Salimetrics Saliva-based Screening Introduction
11.23.4 Salimetrics Revenue in Saliva-based Screening Business (2018-2023)
11.23.5 Salimetrics Recent Development
11.24 NEST Scientific USA
11.24.1 NEST Scientific USA Company Detail
11.24.2 NEST Scientific USA Business Overview
11.24.3 NEST Scientific USA Saliva-based Screening Introduction
11.24.4 NEST Scientific USA Revenue in Saliva-based Screening Business (2018-2023)
11.24.5 NEST Scientific USA Recent Development
11.25 Miraclean Technology Co. Ltd
11.25.1 Miraclean Technology Co. Ltd Company Detail
11.25.2 Miraclean Technology Co. Ltd Business Overview
11.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Introduction
11.25.4 Miraclean Technology Co. Ltd Revenue in Saliva-based Screening Business (2018-2023)
11.25.5 Miraclean Technology Co. Ltd Recent Development
11.26 Mawi DNA Technologies
11.26.1 Mawi DNA Technologies Company Detail
11.26.2 Mawi DNA Technologies Business Overview
11.26.3 Mawi DNA Technologies Saliva-based Screening Introduction
11.26.4 Mawi DNA Technologies Revenue in Saliva-based Screening Business (2018-2023)
11.26.5 Mawi DNA Technologies Recent Development
11.27 Cell Projects Ltd.
11.27.1 Cell Projects Ltd. Company Detail
11.27.2 Cell Projects Ltd. Business Overview
11.27.3 Cell Projects Ltd. Saliva-based Screening Introduction
11.27.4 Cell Projects Ltd. Revenue in Saliva-based Screening Business (2018-2023)
11.27.5 Cell Projects Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details